Pfizer’s stock has fallen 55% from its 2021 peak, pushing its dividend yield to 6.3%, far above the pharmaceutical sector ...
It's acquiring an asset with a very promising lead drug candidate.
For the quickest way to join, simply enter your email below and get access. We will send a confirmation and sign you up to our newsletter to keep you updated on all your gaming news.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results